MBM Wealth Consultants’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.02M | Buy |
12,001
+312
| +3% | +$67.1K | 0.58% | 25 |
|
|
2026
Q1 | $2.54M | Buy |
11,689
+270
| +2% | +$59.9K | 0.58% | 25 |
|
|
2025
Q4 | $2.61M | Sell |
11,419
-256
| -2% | -$58.3K | 0.62% | 24 |
|
|
2025
Q3 | $2.7M | Sell |
11,675
-14
| -0.1% | -$2.85K | 0.67% | 22 |
|
|
2025
Q2 | $2.17M | Buy |
11,689
+97
| +0.8% | +$18K | 0.58% | 25 |
|
|
2025
Q1 | $2.43M | Buy |
11,592
+246
| +2% | +$47.8K | 0.72% | 20 |
|
|
2024
Q4 | $2.04M | Buy |
11,346
+83
| +0.7% | +$15.3K | 0.61% | 23 |
|
|
2024
Q3 | $2.22M | Sell |
11,263
-133
| -1% | -$24.8K | 0.7% | 20 |
|
|
2024
Q2 | $1.91M | Buy |
11,396
+163
| +1% | +$27K | 0.65% | 21 |
|
|
2024
Q1 | $2.05M | Sell |
11,233
-68
| -0.6% | -$11.7K | 0.72% | 19 |
|
|
2023
Q4 | $1.85M | Sell |
11,301
-165
| -1% | -$24.1K | 0.69% | 20 |
|
|
2023
Q3 | $1.7M | Buy |
11,466
+108
| +1% | +$15.9K | 0.74% | 21 |
|
|
2023
Q2 | $1.53M | Buy |
11,358
+737
| +7% | +$108K | 0.66% | 23 |
|
|
2023
Q1 | $1.77M | Hold |
10,621
| – | – | 0.72% | 20 |
|
|
2022
Q4 | $1.73M | Buy |
10,621
+94
| +0.9% | +$14.4K | 0.8% | 19 |
|
|
2022
Q3 | $1.46M | Buy |
10,527
+472
| +5% | +$67.7K | 0.7% | 19 |
|
|
2022
Q2 | $1.54M | Sell |
10,055
-297
| -3% | -$45.4K | 0.75% | 20 |
|
|
2022
Q1 | $1.68M | Buy |
10,352
+20
| +0.2% | +$2.9K | 0.7% | 25 |
|
|
2021
Q4 | $1.4M | Buy |
10,332
+18
| +0.2% | +$2.13K | 0.58% | 27 |
|
|
2021
Q3 | $1.11M | Sell |
10,314
-14
| -0.1% | -$1.6K | 0.51% | 34 |
|
|
2021
Q2 | $1.16M | Sell |
10,328
-34
| -0.3% | -$3.83K | 0.55% | 32 |
|
|
2021
Q1 | $1.12M | Sell |
10,362
-488
| -4% | -$52.2K | 0.57% | 34 |
|
|
2020
Q4 | $1.16M | Sell |
10,850
-37
| -0.3% | -$3.56K | 0.63% | 28 |
|
|
2020
Q3 | $953K | Sell |
10,887
-127
| -1% | -$12K | 0.61% | 28 |
|
|
2020
Q2 | $1.08M | Sell |
11,014
-4,787
| -30% | -$421K | 0.76% | 25 |
|
|
2020
Q1 | $1.25M | Sell |
15,801
-157
| -1% | -$13.4K | 1.03% | 23 |
|
|
2019
Q4 | $1.41M | Sell |
15,958
-1,326
| -8% | -$110K | 1.05% | 26 |
|
|
2019
Q3 | $1.31M | Buy |
17,284
+194
| +1% | +$13.3K | 1.03% | 26 |
|
|
2019
Q2 | $1.26M | Buy |
17,090
+414
| +2% | +$32.5K | 1.05% | 26 |
|
|
2019
Q1 | $1.34M | Buy |
16,676
+342
| +2% | +$28K | 1.18% | 25 |
|
|
2018
Q4 | $1.51M | Buy |
+16,334
| New | +$1.44M | 1.47% | 21 |
|
Other funds holding ABBV
MBM Wealth Consultants's ABBV Position: Q2 2026 in Review
MBM Wealth Consultants increased its AbbVie (ABBV) stake by 2.7% in Q2 2026, buying an estimated $67.1K and bringing the position to 12,001 shares worth $3.02M. The position accounts for 0.58% of the portfolio, ranked #25.
MBM Wealth Consultants first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- MBM Wealth Consultants held 12,001 shares of AbbVie worth $3.02M as of Q2 2026.
- MBM Wealth Consultants bought 312 AbbVie shares in Q2 2026, an estimated $67.1K.
- AbbVie made up 0.58% of MBM Wealth Consultants's portfolio in Q2 2026, its #25 holding.
- MBM Wealth Consultants first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on MBM Wealth Consultants's 13F filing for Q2 2026, filed 24 Jul 2026.